Top

BMC Urology

Published in:

Open Access 01-12-2012 | Research article

Content validity and test-retest reliability of patient perception of intensity of urgency scale (PPIUS) for overactive bladder

Authors: Sherilyn M Notte, Thomas S Marshall, Misun Lee, Zalmai Hakimi, Isaac Odeyemi, Wen-Hung Chen, Dennis A Revicki

Published in: BMC Urology | Issue 1/2012

Abstract

Background

The Patient Perception of Intensity of Urgency Scale (PPIUS) is a patient-reported outcome instrument intended to measure the intensity of urgency associated with each urinary or incontinence episode. The objectives of this study were to assess the content validity, test-retest reliability, and acclimation effect of the PPIUS in overactive bladder (OAB) patients.

Methods

Patients undergoing treatment for OAB were recruited to participate in a non-interventional study by completing a three-day micturition diary including the PPIUS for three consecutive weeks. Following completion of the three-week study, participants from two select sites also completed a cognitive interview to assess their comprehension of the PPIUS.

Results

Thirty-nine participants successfully completed the three-week test-retest study; twelve of these participants completed the cognitive interview. Test-retest reliability was high based on intra-class correlation coefficient of 0.95. Among stable patients, the difference between the mean ratings of any two weeks was non-significant. Among the twelve interview participants, nine found it simple to choose a PPIUS rating for each of their micturition episodes and most found the urgency rating definitions consistent with their urgency experiences.

Conclusions

The results demonstrated content validity based on qualitative interviews, and excellent test-retest reliability among stable patients. In addition, no acclimation effect was observed among stable patients. These findings support the use of the PPIUS as a reliable measure of urgency in both clinical trial and real life settings. The validity of PPIUS could be further established with future studies investigating the relationship between discretely graded urgency and incontinence continuum.

Available only for authorised users

Abrams P, Artibani W, Cardozo L, Dmochowski R, van Kerrebroeck P, Sand P: Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn. 2009, 28: 287-10.1002/nau.20737.CrossRefPubMed

Coyne KS, Payne C, Bhattacharyya SK, Revicki DA, Thompson C, Corey R: The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Health. 2004, 7: 455-463. 10.1111/j.1524-4733.2004.74008.x.CrossRefPubMed

EMA, EMA: Committee for Proprietary Medicinal Products: Note for Guidance on the Clinical Investigation of Medicinal Products for the Treatment of Urinary Incontinence. CPMP/EWP/18/01. 2002, London: EMA (European Medicines Agency)

Cardozo L, Hessdorfer E, Milani R, Arano P, Dewilde L, Slack M, Drogendijk T, Wright M, Bolodeoku J: Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trial. BJU Int. 2008, 102: 1120-1127. 10.1111/j.1464-410X.2008.07939.x.CrossRefPubMed

Dmochowski RR, Newman DK: Impact of overactive bladder on women in the United States: results of a national survey. Curr Med Res Opin. 2007, 23: 65-76. 10.1185/030079907X159533.CrossRefPubMed

Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J: for the Ssg: A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol. 2005, 48: 464-470. 10.1016/j.eururo.2005.05.015.CrossRefPubMed

Cartwright R, Srikrishna S, Cardozo L, Robinson D: Validity and reliability of the patient's perception of intensity of urgency scale in overactive bladder. BJU Int. 2011, 107: 1612-1617. 10.1111/j.1464-410X.2010.09684.x.CrossRefPubMed

Cartwright R, Panayi D, Cardozo L, Khullar V: Reliability and normal ranges for the Patient's Perception of Intensity of Urgency Scale in asymptomatic women. BJU Int. 2010, 105: 832-836. 10.1111/j.1464-410X.2009.08846.x.CrossRefPubMed

Hays RD, Revicki DA: Assessing reliability and validity of measurement in clinical trials. Quality of Life Assessment in Clinical Trials: Methods and Practice. 2005

10.

Jaeschke R, Singer J, Guyatt GH: Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989, 10: 407-415. 10.1016/0197-2456(89)90005-6.CrossRefPubMed

11.

Matza LS, Thompson CL, Krasnow J, Brewster-Jordan J, Zyczynski T, Coyne KS: Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ). Neurourol Urodyn. 2005, 24: 215-225. 10.1002/nau.20110.CrossRefPubMed

12.

Juniper EF, Guyatt GH, Willan A, Griffith LE: Determining a minimal important change in disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1994, 47: 81-87. 10.1016/0895-4356(94)90036-1.CrossRefPubMed

13.

Ware JE, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30: 473-483. 10.1097/00005650-199206000-00002.CrossRefPubMed

14.

Fleiss JL: Statistical Methods for Rates and Proportions. 1981, New York: Wiley

15.

Muhr T: User's Manual for ATLAS.ti 5.0, ATLAS. 2004, Berlin: ti Scientific Software Development GmbH

16.

Ware JE, Kosinski M: SF-36 Physical & Mental Health Summary Scales: A manual for Users of Version 1. 2001, Lincoln, RI: Inc. Q ed, 2

17.

Milsom I, Stewart W, Thuroff J: The prevalence of overactive bladder. Am J Manag Care. 2000, 6: S565-573.PubMed

18.

Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ: How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001, 87: 760-766.CrossRefPubMed

19.

Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzong AR, Corey R: Prevalence and burden of overactive bladder in the United States. World J Urol. 2003, 20: 327-336.PubMed

20.

Temml C, Heidler S, Ponholzer A, Madersbacher S: Prevalence of the overactive bladder syndrome by applying the International Continence Society definition. Eur Urol. 2005, 48: 622-627. 10.1016/j.eururo.2005.04.026.CrossRefPubMed

21.

Starkman JS, Dmochowski RR: Urgency assessment in the evaluation of overactive bladder (OAB). Neurourol Urodyn. 2008, 27: 13-21. 10.1002/nau.20472.CrossRefPubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2490/12/26/prepub

Title: Content validity and test-retest reliability of patient perception of intensity of urgency scale (PPIUS) for overactive bladder
Authors: Sherilyn M Notte
Thomas S Marshall
Misun Lee
Zalmai Hakimi
Isaac Odeyemi
Wen-Hung Chen
Dennis A Revicki
Publication date: 01-12-2012
Publisher: BioMed Central
Published in: BMC Urology / Issue 1/2012
Electronic ISSN: 1471-2490
DOI: https://doi.org/10.1186/1471-2490-12-26

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Content validity and test-retest reliability of patient perception of intensity of urgency scale (PPIUS) for overactive bladder

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2012

Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium

Urethral obstruction from dislodged bladder Diverticulum stones: a case report

Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma

Urinary levels of Hepatocarcinoma-intestine-pancreas/Pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer

Expression of apoptosis-regulating genes in the rat prostate following botulinum toxin type a injection

Unusual stent after ureteral substitution. A first case